Hashemi, E.; Malarkannan, S. Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance. Cancers 2020, 12, 1553
Long, E.O. Ready for prime time: NK cell priming by dendritic cells. Immunity 2007, 26, 385–387.
Vignali DA, Kuchroo VK.IL-12 family cytokines: immunological playmakers.Nat Immunol. 2012 Jul 19;13(8):722-8.
Glassman, C.R.; Mathiharan, Y.K.; Jude, K.M.; Su, L.; Panova, O.; Lupardus, P.J.; Spangler, J.B.; Ely, L.K.; Thomas, C.; Skiniotis, G.; et al. Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells. Cell 2021, 184, 983–999.e4.
Khalil, M.; Wang, D.; Hashemi, E.; Terhune, S.S.; Malarkannan, S. Implications of a ‘Third Signal’ in NK Cells. Cells 2021, 10, 1955.
识别微信二维码,添加细胞基因研究圈小编
请注明:姓名+研究方向!